QUADRANT CAPITAL GROUP LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,2650.0%40
+29.0%
0.00%
Q2 2023$1,265
-82.8%
31
-84.3%
0.00%
-100.0%
Q1 2023$7,343
+1069.3%
197
+994.4%
0.00%
Q4 2022$628
-93.0%
18
-89.2%
0.00%
-100.0%
Q3 2022$9,0000.0%1660.0%0.00%0.0%
Q2 2022$9,000
+200.0%
166
+361.1%
0.00%
Q1 2022$3,000
-57.1%
36
-41.0%
0.00%
-100.0%
Q4 2021$7,000
-63.2%
61
-56.4%
0.00%
-66.7%
Q3 2021$19,000
+90.0%
140
+133.3%
0.00%
+200.0%
Q2 2021$10,000
+233.3%
60
+87.5%
0.00%
Q1 2021$3,00032
+113.3%
0.00%
Q1 2020$0150.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders